INVIVO THERAPEUTICS HOLDINGS (NVIV) Stock Balance Sheet
NASDAQ:NVIV - Nasdaq - US46186M6057 - Common Stock - Currency: USD
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 60.00K | 60.00K | 10.00K | -10.00K | -20.00K | |||
| Cash Equivalents | 8.52M | 16.30M | 19.03M | 19.51M | 6.62M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 940.00K | 1.25M | 110.00K | 160.00K | 180.00K | |||
| Total Current Assets | 9.53M | 17.60M | 19.14M | 19.66M | 6.78M | |||
| Non-Current Assets | ||||||||
| PPE Net | 10.00K | 1.07M | 1.36M | 1.01M | 1.28M | |||
| Intangibles | N/A | N/A | 0.00 | 10.00K | 30.00K | |||
| Other Non-Current Assets | 50.00K | 150.00K | 1.27M | 1.23M | 1.23M | |||
| Total Non-Current Assets | 50.00K | 1.22M | 2.63M | 2.25M | 2.55M | |||
| TOTAL ASSETS | 9.58M | 18.82M | 21.77M | 21.91M | 9.33M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 540.00K | 1.85M | 2.01M | 1.49M | 1.72M | |||
| Accounts Payable | 120.00K | 620.00K | 610.00K | 480.00K | 940.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 670.00K | 2.47M | 2.61M | 1.97M | 2.66M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 610.00K | 1.04M | 750.00K | 1.08M | |||
| Total Non-Current Liabilities | 0.00 | 610.00K | 1.05M | 750.00K | 1.08M | |||
| TOTAL LIABILITIES | 670.00K | 3.08M | 3.66M | 2.72M | 3.74M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -255.59M | -248.62M | -238.13M | -228.23M | -219.16M | |||
| Additional Paid In Capital | 264.50M | 264.36M | 256.24M | 247.42M | 224.74M | |||
| Common Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 3.11M | 2.43M | 1.37M | 950.00K | 20.00K | |||
| Tangible Book Value per Share | 2.87 | 6.48 | 13.23 | 20.19 | 277.50 | |||
| Total Shareholders' Equity | 8.92M | 15.75M | 18.12M | 19.19M | 5.58M | |||
| TOTAL LIABILITIES AND EQUITY | 9.58M | 18.82M | 21.77M | 21.91M | 9.33M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 14.22 | 7.13 | 7.33 | 9.98 | 2.55 | |||
| Return On Assets (ROA) | -97.39% | -55.74% | -45.48% | -41.40% | -126.80% | |||
| Return On Equity (ROE) | -104.60% | -66.60% | -54.64% | -47.26% | -212.01% | |||
All data in USD , ROIC based on taxRate of 0.21